AIDS related malignancies (part 1)

Interview of Ronald T. Mitsuyasu, M.D.
The AIDS Malignancy Consortium (AMC)
is a National Cancer Institute-supported clinical trials group founded in 1995 to support innovative trials for AIDS-associated malignancies. The AMC is composed of 14 main Clinical Trials Sites and their affiliates, and an Operations and Statistical Center. The AMC is committed to enhancing therapeutic options for patients with AIDS-associated malignancies.